LLY
Price
$636.48
Change
+$10.83 (+1.73%)
Updated
Aug 11, 04:41 PM (EDT)
Capitalization
560.87B
80 days until earnings call
OGN
Price
$9.02
Change
-$0.09 (-0.99%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
2.4B
80 days until earnings call
Interact to see
Advertisement

LLY vs OGN

Header iconLLY vs OGN Comparison
Open Charts LLY vs OGNBanner chart's image
Eli Lilly & Co
Price$636.48
Change+$10.83 (+1.73%)
Volume$8.41K
Capitalization560.87B
Organon & Co
Price$9.02
Change-$0.09 (-0.99%)
Volume$195.66K
Capitalization2.4B
LLY vs OGN Comparison Chart in %
Loading...
LLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LLY vs. OGN commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LLY is a Buy and OGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (LLY: $625.65 vs. OGN: $9.11)
Brand notoriety: LLY: Notable vs. OGN: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: LLY: 355% vs. OGN: 1%
Market capitalization -- LLY: $560.87B vs. OGN: $2.4B
LLY [@Pharmaceuticals: Major] is valued at $560.87B. OGN’s [@Pharmaceuticals: Major] market capitalization is $2.4B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $560.87B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $85.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LLY’s FA Score shows that 2 FA rating(s) are green whileOGN’s FA Score has 2 green FA rating(s).

  • LLY’s FA Score: 2 green, 3 red.
  • OGN’s FA Score: 2 green, 3 red.
According to our system of comparison, LLY is a better buy in the long-term than OGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LLY’s TA Score shows that 5 TA indicator(s) are bullish while OGN’s TA Score has 4 bullish TA indicator(s).

  • LLY’s TA Score: 5 bullish, 5 bearish.
  • OGN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, LLY is a better buy in the short-term than OGN.

Price Growth

LLY (@Pharmaceuticals: Major) experienced а -17.93% price change this week, while OGN (@Pharmaceuticals: Major) price change was -6.56% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.59%. For the same industry, the average monthly price growth was +4.02%, and the average quarterly price growth was +11.86%.

Reported Earning Dates

LLY is expected to report earnings on Oct 30, 2025.

OGN is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.59% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LLY($561B) has a higher market cap than OGN($2.4B). LLY has higher P/E ratio than OGN: LLY (40.89) vs OGN (3.43). LLY YTD gains are higher at: -18.651 vs. OGN (-37.674). LLY has higher annual earnings (EBITDA): 16.3B vs. OGN (1.48B). LLY has more cash in the bank: 3.22B vs. OGN (547M). OGN has less debt than LLY: OGN (8.96B) vs LLY (38.5B). LLY has higher revenues than OGN: LLY (49B) vs OGN (6.29B).
LLYOGNLLY / OGN
Capitalization561B2.4B23,404%
EBITDA16.3B1.48B1,101%
Gain YTD-18.651-37.67450%
P/E Ratio40.893.431,193%
Revenue49B6.29B779%
Total Cash3.22B547M589%
Total Debt38.5B8.96B430%
FUNDAMENTALS RATINGS
LLY: Fundamental Ratings
LLY
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
31
SMR RATING
1..100
15
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
44

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LLYOGN
RSI
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
67%
Momentum
ODDS (%)
Bearish Trend 4 days ago
55%
Bearish Trend 4 days ago
66%
MACD
ODDS (%)
Bearish Trend 4 days ago
59%
Bearish Trend 4 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
54%
Bearish Trend 4 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
54%
Bearish Trend 4 days ago
70%
Advances
ODDS (%)
Bullish Trend 18 days ago
69%
Bullish Trend 4 days ago
68%
Declines
ODDS (%)
Bearish Trend 4 days ago
52%
Bearish Trend 12 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
58%
Aroon
ODDS (%)
Bullish Trend 4 days ago
75%
Bearish Trend 4 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
LLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FOKFX28.480.34
+1.21%
Fidelity OTC K6
FIDEX13.680.10
+0.74%
Fidelity SAI Sustainable U.S. Equity Fd
HSUAX40.760.23
+0.57%
Rational Dynamic Brands A
MGIBX40.400.08
+0.20%
MFS International Intrinsic Value B
WFDAX26.39-0.04
-0.15%
Allspring SMID Cap Growth Fund - Cl A

LLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LLY has been loosely correlated with AZN. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if LLY jumps, then AZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LLY
1D Price
Change %
LLY100%
-2.37%
AZN - LLY
39%
Loosely correlated
-0.68%
BIIB - LLY
37%
Loosely correlated
N/A
OGN - LLY
34%
Loosely correlated
N/A
NVO - LLY
33%
Poorly correlated
+4.76%
MRK - LLY
32%
Poorly correlated
+0.40%
More

OGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGN has been loosely correlated with PFE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if OGN jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGN
1D Price
Change %
OGN100%
N/A
PFE - OGN
46%
Loosely correlated
+1.44%
BIIB - OGN
40%
Loosely correlated
N/A
GSK - OGN
39%
Loosely correlated
+0.59%
SNY - OGN
37%
Loosely correlated
-0.63%
JNJ - OGN
35%
Loosely correlated
+1.05%
More